Herbert Y. Meltzer, MD, is Professor of Psychiatry and Behavioral Sciences, Pharmacology and Physiology and Director of the Translational Neuropharmacology Program at Northwestern University in Chicago, IL. He received his BA from Cornell University, an MA in Chemistry from Harvard, and his MD from Yale University. Dr. Meltzer has been President of the American College of Neuropsychopharmacology (ACNP) and the Collegium International Neuro-psychopharmacologicum (CINP). He was co-editor of the ACNP journal, Neuropsychopharmacology. Current research interests include: 1) development of novel drugs for treatment and prevention of psychosis, depression, opioid abuse, and age associated cognitive impairment; 2) behavioral and neurochemical studies of antipsychotic, antidepressant, cognitive improving, and antisuicide drugs; and 3) genetic biomarkers. Dr. Meltzer is the recipient of the Efron and Paul Hoch Awards of the ACNP, the Lieber Prize for Schizophrenia Research from NARSAD/Brain Behavior Research Foundation, the Dean Award for Research in Schizophrenia of the American College of Psychiatry, the Gold Medal Award of the Society of Biological Psychiatry, the Sutherland Prize for Research and Grant Liddle Award for Clinical Research of Vanderbilt University, the Research Prize of the American Psychiatric Association, and the Lifetime Achievement awards from the Schizophrenia International Research Society (SIRS).